Massimo Volpe to Time Factors
This is a "connection" page, showing publications Massimo Volpe has written about Time Factors.
Connection Strength
0.239
-
COVID-19 and the Forgotten Majority. High Blood Press Cardiovasc Prev. 2020 Oct; 27(5):339.
Score: 0.041
-
Legacy Effect in the Treatment of Hypertension: Persistent Cardiovascular Protection after Conclusion of Randomized Clinical Trials in Hypertension. Curr Hypertens Rep. 2019 10 10; 21(11):85.
Score: 0.038
-
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan. Cardiovasc Ther. 2018 Dec; 36(6):e12471.
Score: 0.036
-
Is early and fast blood pressure control important in hypertension management? Int J Cardiol. 2018 03 01; 254:328-332.
Score: 0.034
-
Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control. High Blood Press Cardiovasc Prev. 2017 Sep; 24(3):255-263.
Score: 0.033
-
Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control. High Blood Press Cardiovasc Prev. 2017 Sep; 24(3):243-253.
Score: 0.033
-
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 12 01; 122(11):1924-1931.
Score: 0.009
-
Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy. Clin Cardiol. 2018 Jun; 41(6):788-796.
Score: 0.009
-
Long-Term Outcome of Acute Coronary Syndromes in Young Patients. High Blood Press Cardiovasc Prev. 2017 Mar; 24(1):77-84.
Score: 0.008